SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20FR12G/A - Registration of securities [Section 12(g)]: [Amend]
SEC Accession No. 0000950131-97-002492
Filing Date
1997-04-09
Accepted
1997-04-09 00:00:00
Documents
1
SROs
NONE

Document Format Files

Seq Description Document Type Size
1 FORM 20-F AMENDMENT #6 20FR12G/A 205830
  Complete submission text file 0000950131-97-002492.txt   207262
Mailing Address 175 BOUCHARD, STE 100 DORVAL, QUEBEC CANADA, H9S 1B1 A8
Business Address 175 BOUCHARD, STE 100 DORVAL, QUEBEC CANADA H9S 1B1 A8 5146363122
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20FR12G/A | Act: 34 | File No.: 001-12033 | Film No.: 97577465
SIC: 2835 In Vitro & In Vivo Diagnostic Substances